Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy-Reference-Cited by-同舟云学术

Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted Therapy

Published:2011-07-01 Issue:7 Volume:2 Page:538-550
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Sokolosky Melissa L.¹²,Stadelman Kristin M.¹²,Chappell William H.¹,Abrams Stephen L.¹,Martelli Alberto M.³⁴,Stivala Franca⁵,Libra Massimo⁵,Nicoletti Ferdinando⁵,Drobot Lyudmyla B.⁶,Franklin Richard A.¹,Steelman Linda S.¹,McCubrey James A.¹

Affiliation:

1. Department of Microbiology & Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27858 USA

2. These two authors contributed equally to the studies.

3. Dipartimento di Scienze Anatomiche Umane e Fisiopatologia dell'Apparato Locomotore, Università di Bologna, Bologna, Italy

4. IGM-CNR, Sezione di Bologna, C/o IOR, Bologna, Italy

5. Department of Biomedical Sciences, University of Catania, Catania, Italy

6. Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv, Ukraine

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introduction to Drug Resistance in Cancer;Drug Resistance in Cancer: Mechanisms and Strategies;2024

2. Anlotinib Inhibits Proliferation and Induces Apoptosis in B-cell Acute Lymphoblastic Leukemia by Targeting the BTK and AKT/mTOR Pathway;Anti-Cancer Agents in Medicinal Chemistry;2023-07-10

3. Long noncoding RNA CCAT2 reduces chemosensitivity to 5‐fluorouracil in breast cancer cells by activating the mTOR axis;Journal of Cellular and Molecular Medicine;2022-02-15

4. Clinical Review on the Management of Hormone Receptor–Positive Metastatic Breast Cancer;JCO Oncology Practice;2021-10-12

5. Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma;International Journal of Oncology;2021-09-14